Market Overview:
The global hydroxychloroquine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of autoimmune diseases, rising awareness about hydroxychloroquine and its benefits, and growing investments by key players in research and development (R&D) activities. Based on type, the global hydroxychloroquine market is segmented into 100 mg, 200 mg, and other types. The 200 mg type segment is expected to account for the largest share of the global hydroxychloroquine market in 2018. This can be attributed to its higher efficacy as compared to other types of hydroxychloroquine formulations available in the market. Based on application, the global Hydroxy chloroquin Market is segmented into lupus erythematosus (LE), rheumatoid arthritis (RA), Sjögren’s syndrome (SS), dermatomyositis/polymyositis (DM/PM), systemic sclerosis (SSc), mixed connective tissue disease(MCTD) ,and others.
Product Definition:
A synthetic, antimalarial drug that is also effective in the treatment of rheumatoid arthritis. Hydroxychloroquine interferes with the metabolism of hemoglobin in malaria-infected cells, preventing the parasite from replicating. It is also a potent anti-inflammatory agent and may be useful in treating other autoimmune diseases.
100 mg:
Hydroxychloroquine, also known as hydroxychloroquine sulfate or hydroxychloroquine, is an immunosuppressive drug with anti-viral properties. It's primary function is to reduce the severity and frequency of malaria by inhibiting Plasmodium falciparum growth. Hydroxychloroquinq has a wide range of applications in veterinary medicine including treatment of avian malaria and as prophylactic for susceptible birds.
200 mg:
Hydroxychloroquine, also known as hydroxychloroquine sulfate or Hydroxychlorox (HCQ), is an immunosuppressive drug with anti-viral properties. It is used for the treatment of viral diseases such as malaria and auto-immune diseases such as lupus and rheumatoid arthritis. 200 mg tablet contains 200 mg base/100 mg salt combination of hydroxychloroquine. The U.
Application Insights:
The others segment dominated the global market in terms of revenue share in 2017. This is due to the presence of applications such as osteoarthritis, rheumatoid arthritis and lupus erythematosus which are gaining significant popularity among patients worldwide. The osteoarthritis application segment is expected to be one of the major growth drivers during the forecast period owing to its high prevalence rate globally. According to a study conducted by researchers at UPEK, around 54 million people aged over 50 years have some form of osteoarthritis while around 24 million people aged between 20-49 years have been diagnosed with this condition.
Rheumatoid arthritis was found to be one of the most common chronic diseases affecting humans across all age groups.
Regional Analysis:
North America was the leading revenue contributor in 2017. The region is anticipated to maintain its dominance over the forecast period as well. This can be attributed to increasing awareness about hydroxychloroquine-based drugs, rising preference for OTC products, and presence of a large number of manufacturers in this region.
Asia Pacific is expected to witness significant growth during the forecast period owing to growing target population base and expanding distribution network of major players operating in this market. Moreover, availability of generic versions will also help boost demand for HOCQ tablets over the coming years. China has one of the largest production facilities that caters to almost 50% global demand thus making it a key player in this industry’s evolution throughout Asia Pacific region (APAC). India also contributes significantly towards regional growth due high consumption rates coupled with availability & affordable pricing strategies implemented by major players such as Cipla Inc.; FDC Limited; Sun Pharmaceutical Industries Ltd.
Growth Factors:
- Increasing prevalence of autoimmune diseases: Hydroxychloroquine is used to treat a variety of autoimmune diseases, which is expected to drive the market growth.
- Rising awareness about the benefits of hydroxychloroquine: There is a growing awareness among physicians and patients about the benefits of hydroxychloroquine, which is likely to boost demand for the drug in the coming years.
- Growing use of hydroxychloroquine in combination therapy: Hydroxychloroquine is increasingly being used in combination with other drugs for better treatment outcomes, thereby propelling market growth.
- Launch of new products: Several pharmaceutical companies are launching new products that contain hydroxychloroquine, providing impetus to market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydroxychloroquine Market Research Report
By Type
100 mg, 200 mg, Other
By Application
Lupus Erythematosus, Rheumatoid Arthritis, Others
By Companies
Sanofi, Novartis, Shanghai Zhongxisanwei, Teva, Zydus Cadila, Mylan, Apotex, Advanz Pharma, Sun Pharma, Kyung Poong, Ipca Laboratories, Hanlim Pharmaceutical, Bristol Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
149
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Hydroxychloroquine Market Report Segments:
The global Hydroxychloroquine market is segmented on the basis of:
Types
100 mg, 200 mg, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lupus Erythematosus, Rheumatoid Arthritis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Novartis
- Shanghai Zhongxisanwei
- Teva
- Zydus Cadila
- Mylan
- Apotex
- Advanz Pharma
- Sun Pharma
- Kyung Poong
- Ipca Laboratories
- Hanlim Pharmaceutical
- Bristol Laboratories
Highlights of The Hydroxychloroquine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 100 mg
- 200 mg
- Other
- By Application:
- Lupus Erythematosus
- Rheumatoid Arthritis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydroxychloroquine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hydroxychloroquine is a medication used to treat malaria. It works by stopping the growth of the parasite in your body.
Some of the key players operating in the hydroxychloroquine market are Sanofi, Novartis, Shanghai Zhongxisanwei, Teva, Zydus Cadila, Mylan, Apotex, Advanz Pharma, Sun Pharma, Kyung Poong, Ipca Laboratories, Hanlim Pharmaceutical, Bristol Laboratories.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hydroxychloroquine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hydroxychloroquine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hydroxychloroquine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hydroxychloroquine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hydroxychloroquine Market Size & Forecast, 2018-2028
4.5.1 Hydroxychloroquine Market Size and Y-o-Y Growth
4.5.2 Hydroxychloroquine Market Absolute $ Opportunity
Chapter 5 Global Hydroxychloroquine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hydroxychloroquine Market Size Forecast by Type
5.2.1 100 mg
5.2.2 200 mg
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hydroxychloroquine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hydroxychloroquine Market Size Forecast by Applications
6.2.1 Lupus Erythematosus
6.2.2 Rheumatoid Arthritis
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hydroxychloroquine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hydroxychloroquine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hydroxychloroquine Analysis and Forecast
9.1 Introduction
9.2 North America Hydroxychloroquine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hydroxychloroquine Market Size Forecast by Type
9.6.1 100 mg
9.6.2 200 mg
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hydroxychloroquine Market Size Forecast by Applications
9.10.1 Lupus Erythematosus
9.10.2 Rheumatoid Arthritis
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hydroxychloroquine Analysis and Forecast
10.1 Introduction
10.2 Europe Hydroxychloroquine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hydroxychloroquine Market Size Forecast by Type
10.6.1 100 mg
10.6.2 200 mg
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hydroxychloroquine Market Size Forecast by Applications
10.10.1 Lupus Erythematosus
10.10.2 Rheumatoid Arthritis
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hydroxychloroquine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hydroxychloroquine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hydroxychloroquine Market Size Forecast by Type
11.6.1 100 mg
11.6.2 200 mg
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hydroxychloroquine Market Size Forecast by Applications
11.10.1 Lupus Erythematosus
11.10.2 Rheumatoid Arthritis
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hydroxychloroquine Analysis and Forecast
12.1 Introduction
12.2 Latin America Hydroxychloroquine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hydroxychloroquine Market Size Forecast by Type
12.6.1 100 mg
12.6.2 200 mg
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hydroxychloroquine Market Size Forecast by Applications
12.10.1 Lupus Erythematosus
12.10.2 Rheumatoid Arthritis
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hydroxychloroquine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hydroxychloroquine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hydroxychloroquine Market Size Forecast by Type
13.6.1 100 mg
13.6.2 200 mg
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hydroxychloroquine Market Size Forecast by Applications
13.10.1 Lupus Erythematosus
13.10.2 Rheumatoid Arthritis
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hydroxychloroquine Market: Competitive Dashboard
14.2 Global Hydroxychloroquine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Novartis
14.3.3 Shanghai Zhongxisanwei
14.3.4 Teva
14.3.5 Zydus Cadila
14.3.6 Mylan
14.3.7 Apotex
14.3.8 Advanz Pharma
14.3.9 Sun Pharma
14.3.10 Kyung Poong
14.3.11 Ipca Laboratories
14.3.12 Hanlim Pharmaceutical
14.3.13 Bristol Laboratories
